You're reading the free version. Trader adds the live tape and alerts.
Start tracking
SGMT Exercise Disclosure
Kemble George · SEC Form 4 · Filed Aug 17, 2026
Exercise
Calculated transaction value
$0
Kemble George Director
SGMT
Transaction date
Aug 14, 2026
Public filing date
Aug 17, 2026
Filing lag
Filed 3 days later
SGMT daily price context
Close on/before transaction
$10.55
Aug 14, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Option (Right to Buy) on Series A Common Stock
- Quantity / price
- 326,618 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001193125-26-354018
Filing cohort
Transactions in this filing
Showing 5 of 5
Trades
5
Issuers
1
Estimated value
$5.82M
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Sagimet Biosciences Inc. SGMT | Exercise | Aug 14, 2026 | $2.08M |
| Sagimet Biosciences Inc. SGMT | Exercise | Aug 14, 2026 | $154.99K |
| Sagimet Biosciences Inc. SGMT | Sale | Aug 14, 2026 | $3.59M |
| Sagimet Biosciences Inc. SGMT Current | Exercise | Aug 14, 2026 | $0 |
| Sagimet Biosciences Inc. SGMT | Exercise | Aug 14, 2026 | $0 |